5184.0 Substance Use & HIV/AIDS

Wednesday, November 2, 2011: 12:30 PM
As HIV has become an infection that may be managed much like other chronic diseases, a focus on treatment and prevention continues. Efforts to conduct HIV testing, engage infected individuals in care, and reduce HIV transmission risk are priorities as HIV prevalence rates increase. The HIV/AIDS Section seeks to disseminate study findings related to substance use disorders and their relationship to HIV. This session is aimed to share latest research on topics related to substance use disorders, risk engagement, and treatment opportunities. The section identified this area as a priority, as substance use has consistently been identified as a predictor of HIV infection. The section supported the development of session in order to share innovative approaches to substance use.
Session Objectives: Describe how illicit drug use impacts HIV risk Identify opportunities to address HIV risk in existing substance use programs
Bonnie Chakravorty, PhD, MSW, CHES

12:30 PM
Does Drinking Frequency Matter?: Understanding the Relationship between Alcohol Use, Sexual Risk, and Prior Abuse Among African-American Adolescent Females
Jennifer L. Brown, PhD, Jessica M. Sales, PhD, Ralph J. DiClemente, PhD, Teaniese P. Latham, MPH, Andrea Swartzendruber, MPH and Eve S. Rose, MSPH
12:50 PM
Implementation of Nurse-Initiated HIV Rapid Testing in VA Substance Use Disorder Clinics
Erin Conners, MPH, Jaimi Butler, MA, Hildi Hagedorn, PhD, Patricia Wilson, RN, MSN, MA, Kandi Felmet, BS, Helen Bonanomi, MSN, RN-BC, CARN, Gretchen Haas, PhD, Gloria Klima, MA, Eileen Sudzina, BS, MT (ASCP) and Henry Anaya, PhD
1:10 PM
Long-term alcohol consumption trajectories in adult women with and without HIV infection
Robert L. Cook, MD, MPH, Fang Zhu, PhD, Bea Belnap, Dr Biol Hum, Kathleen Weber, Stephen Cole, PhD, David Vlahov, PhD, Judith A. Cook, PhD, Nancy Hessol, MSPH, Tracey E. Wilson, PhD, Michael W. Plankey, PhD, Andrea Howard, MD, MS, Gerald Sharp, DrPH, Jean Richardson, PhD and Mardge H. Cohen, MD
1:30 PM
Episodic Analysis of Illicit Drug Use and Sexual Risk Taking in YMSM Ages 13-29 in NYC
Robert W. Moeller, EdM, Perry Halkitis, PhD, MS and Daniel Siconolfi, MPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: HIV/AIDS
Endorsed by: Alcohol, Tobacco, and Other Drugs

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)

See more of: HIV/AIDS